Sep 22, 2021

Tumor sequencing panel screens for both somatic and germline changes of clinical significance

The GSC has developed a next-generation sequencing test that can identify both acquired and inherited gene changes in tumor tissue. A paper published in the Journal of Molecular Diagnostics explains how this information can be used in the clinical management of patients with advanced cancers and their families.
Back to top